ACTINIUM PHARMACEUTICALS, INC. Amortization of Debt Discount (Premium)
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Amortization of Debt Discount (Premium) of $900.00 thousand for the 166-month period ending 2014-03-31, per its 10-Q filed 2014-05-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2014-05-12
- ACTINIUM PHARMACEUTICALS, INC. amortization of debt discount (premium) for the quarter ending 2012-12-31 was $97.52K.
- ACTINIUM PHARMACEUTICALS, INC. amortization of debt discount (premium) for the quarter ending 2012-09-30 was $226.85K.
- ACTINIUM PHARMACEUTICALS, INC. amortization of debt discount (premium) for the quarter ending 2012-06-30 was $229.35K.
- ACTINIUM PHARMACEUTICALS, INC. amortization of debt discount (premium) for the quarter ending 2012-03-31 was $221.92K.
- ACTINIUM PHARMACEUTICALS, INC. amortization of debt discount (premium) for fiscal 2012 was $775.64K, a 523.69% increase from fiscal 2011.
- ACTINIUM PHARMACEUTICALS, INC. amortization of debt discount (premium) for fiscal 2011 was $124.36K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month | Amortization of Debt Discount (Premium) 151 month | Amortization of Debt Discount (Premium) 154 month | Amortization of Debt Discount (Premium) 157 month | Amortization of Debt Discount (Premium) 160 month | Amortization of Debt Discount (Premium) 163 month | Amortization of Debt Discount (Premium) 166 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $900.00K 10-Q · filed 2014-05-12 | |||||||||
| 2013-12-31 | $900.00K 10-K · filed 2014-02-28 | |||||||||
| 2013-09-30 | $900.00K 10-Q · filed 2013-11-14 | |||||||||
| 2013-06-30 | $900.00K 10-Q · filed 2013-08-13 | |||||||||
| 2013-03-31 | $900.00K 10-Q · filed 2013-05-15 | |||||||||
| 2012-12-31 | $97.52K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $324.37K derived: sum of 2 quarters · filed 2014-02-28 | $553.72K derived: sum of 3 quarters · filed 2014-02-28 | $775.64K 10-K · filed 2014-02-28 | $900.00K 10-K · filed 2013-03-29 | |||||
| 2012-09-30 | $226.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $456.20K derived: sum of 2 quarters · filed 2013-11-14 | $678.12K 10-Q · filed 2013-11-14 | |||||||
| 2012-06-30 | $229.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $451.27K 10-Q · filed 2013-08-13 | ||||||||
| 2012-03-31 | $221.92K 10-Q · filed 2013-05-15 | |||||||||
| 2011-12-31 | $124.36K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |